What Pharma Wants You to See—But Can’t Submit
How can healthcare stakeholders gain a more complete understanding of a therapy’s value when important evidence and insights may never make it into formal submissions?
As evidence expectations continue to evolve, traditional comprehensive dossiers may no longer fully address the needs of today’s decision-makers. In this Clinical Pathways NEXT session, experts explore a more flexible approach to the dossier concept, examining the gaps between what pharmaceutical manufacturers can submit and what payers, providers, and other stakeholders want to know. The discussion highlights the data and insights manufacturers consider most impactful, the barriers that limit their inclusion, and the opportunities for greater transparency and collaboration.
If you're involved in evidence evaluation, market access, formulary decision-making, or pathway strategy, this conversation will provide valuable perspective on the future of healthcare decision support.
Download the webinar now — free — and gain insights into how a more adaptive, transparent approach to evidence sharing could support better-informed decisions and ultimately improve patient care. Fill out the form below to access.
